NCT02602275View on ClinicalTrials.gov

Neuronal Correlates of Neurexan® Action in Mildly to Moderately Stressed Probands

PHASE2CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Acute Stress Reaction
Interventions
DRUG

Neurexan

0.6 mg / tablet

DRUG

Placebo

Neurexan-matched Placebo tablet

Trial Locations (1)

Unknown

Clinical Affective Neuroimaging Laboratory (CANLAB), Magdeburg

All Listed Sponsors
lead

Biologische Heilmittel Heel GmbH

INDUSTRY

NCT02602275 - Neuronal Correlates of Neurexan® Action in Mildly to Moderately Stressed Probands | Biotech Hunter | Biotech Hunter